Michael Schmertzler, Director at CYTOKINETICS INC (CYTK), sold 402,100 shares at $3.04 ($1.2M) on 2010-05-05, disclosed to the SEC on 2010-05-07.
Open-market sale of $1.2M CYTK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2026-09-18 | $1.3M | — | Filing → |
| PTCT | SELL | 2026-09-11 | $1.4M | — | Filing → |
| PTCT | SELL | 2026-08-28 | $1.8M | — | Filing → |